Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma

Clinical trial NCT04558931 · RECRUITING

Trial details

NCT number: NCT04558931
Sponsor: Karolinska Institutet
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-06-02
Primary completion: 2027-12-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.